Search

Your search keyword '"Bravi, Carlo"' showing total 484 results

Search Constraints

Start Over You searched for: Author "Bravi, Carlo" Remove constraint Author: "Bravi, Carlo"
484 results on '"Bravi, Carlo"'

Search Results

101. PD45-11 PERI-OPERATIVE OUTCOMES OF OPEN VERSUS ROBOT-ASSISTED SIMPLE PROSTATECTOMY: RESULTS FROM TWO HIGH-VOLUME CENTRES

102. MP23-01 URETHRECTOMY AT THE TIME OF RADICAL CYSTECTOMY FOR NON-METASTATIC UROTHELIAL CARCINOMA OF THE BLADDER: A COLLABORATIVE MULTICENTER STUDY

103. MP51-08 DOES A POSITIVE MULTI-PARAMETRIC MRI ALWAYS WARRANT PROSTATE BIOPSY? THE IMPORTANCE OF INTEGRATING CLINICAL AND IMAGING DATA BASED ON A LARGE, MULTI-INSTITUTIONAL SERIES

104. MP48-12 OPTIMIZING TIMING AND INDICATIONS FOR 68GA-PSMA PET/CT IN PATIENTS WITH BIOCHEMICAL RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY

105. MP53-01 DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN MPMRI VISIBLE LESIONS: SIZE MATTERS. RESULTS FROM A LARGE, TWO-INSTITUTIONAL SERIES

106. MP57-17 THE COLLAR TECHNIQUE FOR APICAL DISSECTION DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: UPDATED SERIES AFTER FIVE YEARS FROM ITS INTRODUCTION

107. PD27-05 RELIABILITY OF 68GA-PSMA PET/CT IN ASSESSING REAL NODAL BURDEN IN MEN WITH CN1 DISEASE: CLINICAL IMPLICATIONS FOR PATIENT COUNSELLING AND MULTI-MODAL TREATMENTS

108. MP48-14 WHEN NODE-POSITIVE PROSTATE CANCER SHOULD BE CONSIDERED A SYSTEMIC DISEASE? ASSESSING THE PROGNOSTIC ROLE OF PREOPERATIVE 68GA-PSMA PET/CT RESULTS IN PATIENTS WITH LYMPH NODE INVASION AT FINAL PATHOLOGY

109. MP51-14 IMPACT OF 68GA-PSMA PET/CT AND METASTASIS-DIRECTED THERAPY ON CLINICAL RECURRENCE IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY. RESULTS FROM A SINGLE CENTER SERIES

110. PD60-02 CAN PELVIC LYMPH NODE DISSECTION BE OMITTED AT THE TIME OF RADICAL PROSTATECTOMY IN PATIENTS WITH A NEGATIVE PREOPERATIVE 68GA-PSMA PET/CT? THE IMPORTANCE OF PATIENT RISK STRATIFICATION ACCORDING TO INDIVIDUAL RISK OF LYMPH NODE METASTASES

111. MP48-13 THE KEY ROLE OF CONCOMITANT ANDROGEN-DEPRIVATION THERAPY ON THE EFFICACY OF IMAGING GUIDED TREATMENTS IN MEN WITH BIOCHEMICAL RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY AND POSITIVE 68GA-PSMA PET/CT SCAN

112. Potential Contenders for the Leadership in Robotic Surgery

114. A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaboration.

116. The Surgical Learning Curve for Cancer Control after Robot-Assisted Radical Prostatectomy

117. Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification

118. Correction to: Concomitant robot-assisted laparoscopic surgeries for upper and lower urinary tract malignancies: a comprehensive literature review

119. Concomitant robot-assisted laparoscopic surgeries for upper and lower urinary tract malignancies: a comprehensive literature review

121. Does using a laser improve outcomes of conventional circumcision in adult and children populations? Results from a systematic review and meta‐analysis.

122. Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.

123. Robot‐assisted radical prostatectomy feasibility and setting with the Hugo™ robot‐assisted surgery system.

124. Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis

125. MP05-11 THE LEARNING CURVE OF MPMRI TARGETED BIOPSY FOR THE DETECTION OF CLINICALLY SIGNICANT PROSTATE CANCER IS RELATED TO THE CHARACTERISTICS OF THE INDEX LESION

126. MP11-09 ADDED VALUE OF RADIOLOGICAL TUMOR STAGE IN PREDICTING EARLY ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY WITHIN CLINICAL STAGE: A STAGE-BY-STAGE ANALYSIS

127. PD57-12 WHICH PATIENTS WITH OLIGOMETASTATIC PROSTATE CANCER SHOULD BE CONSIDERED FOR CYTOREDUCTIVE RADICAL PROSTATECTOMY AS PART OF A MULTIMODAL TREATMENT? RESULTS FROM A LARGE, MULTI-INSTITUTIONAL COLLABORATION

128. MP05-12 SHOULD WE ROUTINELY RECOMMEND A CENTRAL REVIEW OF MAGNETIC RESONANCE IMAGING OF THE PROSTATE IN MEN WITH POSITIVE MP-MRI? IMPLICATION FOR TARGETED BIOPSIES

129. MP13-02 ROBOT-ASSISTED CYSTECTOMY WITH INTRACORPOREAL URINARY DIVERSION AFTER PELVIC IRRADIATION FOR PROSTATE CANCER: TECHNIQUE AND RESULTS FROM A SINGLE HIGH-VOLUME CENTER

130. PD08-05 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM PREDICTING LONG-TERM PROGRESSION IN PATIENTS TREATED WITH EARLY SALVAGE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY: THE KEY ROLE OF PSA KINETICS

131. MP62-20 THE DETECTION OF A PI-RADS 4-5 LESION AT MULTIPARAMETRIC MRI BEFORE CONFIRMATORY BIOPSY IS THE STRONGEST PREDICTOR OF DISEASE PROGRESSION AMONG MEN WITH LOW-RISK PROSTATE CANCER INCLUDED IN AN ACTIVE SURVEILLANCE PROSPECTIVE PROTOCOL

132. PD61-09 FINAL RESULTS OF A PROSPECTIVE, RANDOMIZED CONTROLLED TRIAL ASSESSING THE IMPACT OF EARLY DORSAL VENOUS COMPLEX (eDVC) LIGATION ON URINARY CONTINENCE RECOVERY AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY

133. PD57-10 OPTIMIZING THE NUMBER OF SYSTEMATIC CORES DURING AN MRI TARGET BIOPSY: PRELIMINARY RESULTS FROM THE PROSPECTIVE, SINGLE CENTER SCOT TRIAL (NCT 04183699)

134. Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution

135. MP05-13 SATURATION OF THE MPMRI LESION IS NOT NECESSARY TO MINIMIZE THE RISK OF MISSING CLINICALLY SIGNIFICANT PROSTATE CANCER AT TARGETED BIOPSY. ANALYSIS OF A LARGE, MULTI-INSTITUTIONAL SERIES

136. MP49-20 SUTURELESS TECHNIQUE IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY: RESULTS FROM A PROPENSITY-SCORE MATCHED ANALYSIS

137. Toward Individualized Approaches to Partial Nephrectomy: Assessing the Correlation Between Ischemia Time and Patient Health Status (RECORD2 Project)

138. Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series

139. How to Select the Optimal Candidates for Renal Mass Biopsy

141. Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma

144. Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project)

145. Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer

147. Robotic-assisted versus open simple prostatectomy: Results from a systematic review and meta-analysis of comparative studies

149. Editorial Comment from Dr Martiniet al. to Independent external validation of a nomogram to define risk categories for a significant decline in estimated glomerular filtration rate after robotic‐assisted partial nephrectomy

150. Using biomarkers in patients with positive multiparametric magnetic resonance imaging: 4Kscore predicts the presence of cancer outside the index lesion

Catalog

Books, media, physical & digital resources